Participation in the PMA CtQ pilot program is voluntary – the program aims to evaluate device design and manufacturing process quality information early on to assist the FDA in its review of the PMA manufacturing section and post-approval inspections. This voluntary pilot program is part of the FDA’s ongoing Case for Quality effort to apply innovative strategies that promote medical device quality, and is a joint effort between the FDA’s CDRH and Office of Regulatory Affairs (ORA). The program is intended to provide qualifying PMA applicants with the option to engage the FDA on development of CtQ controls for their device and forego the standard PMA pre-approval inspection. FDA would in turn, focus on the PMA applicant’s implementation of the CtQ controls during a postmarket inspection. FDA is seeking companies to volunteer to participate. Full information is at the link provided. Premarket Approval Application Critical to Quality Pilot Program
